Liang, Tingbo

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

Kelley, R. K., Ueno, M., Yoo, C., Finn, R. S., Furuse, J., Ren, Z., Yau, T., Klümpen, H.-J., Chan, S. L., Ozaka, M., et al. (2023) · The Lancet

Cholangiocarcinoma and Gallbladder Cancer StudiesPediatric Hepatobiliary Diseases and Treatments

Cited by 1,169

The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis

Xu, D., Wang, Z., Xia, Y., Shao, F., Xia, W., Wei, Y., Li, X., Qian, X., Lee, J.-H., Du, L., et al. (2020) · Nature

Cancer, Lipids, and MetabolismLipid metabolism and biosynthesis

Cited by 360

Large-scale pancreatic cancer detection via non-contrast CT and deep learning

Cao, K., Xia, Y., Yao, J., Han, X., Lambert, L., Zhang, T., Tang, W., Jin, G., Jiang, H., Fang, X., et al. (2023) · Nature Medicine

AI in cancer detectionRadiomics and Machine Learning in Medical Imaging

Cited by 358

Hypoxia‐inducible factor‐1α/interleukin‐1β signaling enhances hepatoma epithelial–mesenchymal transition through macrophages in a hypoxic‐inflammatory microenvironment

Zhang, J., Zhang, Q., Lou, Y., Fu, Q., Chen, Q., Wei, T., Yang, J., Tang, J., Wang, J., Chen, Y., et al. (2018) · Hepatology

Immune cells in cancerCancer, Hypoxia, and Metabolism

Cited by 286

VISTA: an immune regulatory protein checking tumor and immune cells in cancer immunotherapy

Huang, X., Zhang, X., Li, E., Zhang, G., Wang, X., Tang, T., Bai, X., & Liang, T. (2020) · Journal of Hematology & Oncology

Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology

Cited by 231

Endogenous Interleukin 18 Suppresses Liver Regeneration After Hepatectomy in Mice

Ma, T., Zhang, Y., Lao, M., Chen, W., Hu, Q., Zhi, X., Chen, Z., Bai, X., Dang, X., & Liang, T. (2020) · Liver Transplantation

Liver physiology and pathologyOrgan Transplantation Techniques and Outcomes

Cited by 8